Runx2 調節された呼吸道ホメオスタシスは,喘息で乱されます
Junfei Wang1,2, Alen Faiz3,4,5,6,7, Qi Ge2,8
1Department of Pulmonary and Critical Care Medicine, Qilu Hospital of Shandong University, Jinan, Shandong, China.
まとめ
ラント関連転写因子-2 (RUNX2) は,喘息では低下し,呼吸道の再編成に寄与します. RUNX2のレベルを回復することは,喘息とその関連した呼吸道平滑筋の大量管理のための新しい治療戦略を提供することができます.
科学分野:
- 肺内医学 肺内医学 肺内医学
- 細胞生物学 細胞生物学
- 分子生物学は分子生物学である.
背景:
- 空気路の滑らかな筋肉 (ASM) の体積の増加によって特徴づけられる空気路の改造は,喘息の特徴です.
- 変形成長因子 (TGF) -β1と結合組織成長因子 (CTGF) は,ASMの改造を促進する重要な媒介者です.
- ラント関連転写因子-2 (RUNX2) は,SMAD3相互作用を通じてTGF-β1誘発CTGFを抑制することが知られている.
研究 の 目的:
- 喘息と非喘息ASM細胞におけるRUNX2の発現と機能的役割を調査する.
- 呼吸道炎症に対するRUNX2調節の影響を調査し,喘息におけるマーカーの再構築.
主な方法:
- 孤立したASM細胞と肺組織におけるRUNX2mRNAとタンパク質の定量分析は,マイクロレイ,PCR,ウエスタンブロット,免疫ヒストキミストリーを用いて行われました.
- 不死化した喘息ASM細胞におけるRUNX2イソフォームの過剰発現は,炎症とリモデリングマーカーの影響を評価するために.
- 喘息患者および健康な個人からの支氣管バイオプシにおけるRUNX2代替スプライシングの分析.
主要な成果:
- 喘息患者からのASM細胞では,非喘息の対照群と比較して,RUNX2の濃度が有意に低下した.
- TGF-β1刺激は,非喘息のASM細胞と喘息のASM細胞のRUNX2発現に差異的に影響し,SMAD3活性化に影響を与えました.
- 喘息ASM細胞におけるRUNX2イソフォーム過剰発現は,IL-6レベルに影響を与えることなく,リモデリング (CTGF),高縮,増殖のマーカーを低下させた.
- 増加したRUNX2 mRNAスプライシングは,喘息 bronchial biopsiesで観察されました.
結論:
- RUNX2は,健康な個体において,呼吸道平滑筋ホメオスタシスの維持に重要な役割を果たします.
- 喘息におけるRUNX2発現の減少は,呼吸道滑らかな筋肉の再構築に寄与する.
- RUNX2機能の回復は,喘息治療の潜在的治療方法を示しています.
さらに関連する動画
13:10Evaluation of Respiratory System Mechanics in Mice using the Forced Oscillation Technique
Published on: May 15, 2013
58.4K
10:39Advanced Imaging of Lung Homing Human Lymphocytes in an Experimental In Vivo Model of Allergic Inflammation Based on Light-sheet Microscopy
Published on: April 16, 2019
8.2K
関連する概念動画
01:26Asthma-II: Pathophysiology and Classification
4.6K
Asthma is a prevalent chronic respiratory condition marked by inflammation and hyperresponsiveness of the airways. Its pathophysiology involves complex interactions among inflammatory pathways, immune responses, and neural mechanisms.
Additionally, environmental and genetic factors play crucial roles in determining an individual's susceptibility to asthma and the severity of their condition.
Critical processes in asthma pathophysiology include:
Additionally, environmental and genetic factors play crucial roles in determining an individual's susceptibility to asthma and the severity of their condition.
Critical processes in asthma pathophysiology include:
4.6K
01:20Asthma: Pathogenesis and Management
1.4K
Asthma is a chronic pulmonary condition involving inflammation of the airways, hyper-reactivity, and reversible obstruction of the airways. This condition can significantly impact a person's quality of life, making breathing difficult and leading to distressing symptoms.
Asthma is classified as allergic and non-allergic. Allergens such as dust mites, pollen, and pet dander trigger allergic asthma, while factors like cold air, intense emotions, or exercise can induce non-allergic asthma.
Asthma is classified as allergic and non-allergic. Allergens such as dust mites, pollen, and pet dander trigger allergic asthma, while factors like cold air, intense emotions, or exercise can induce non-allergic asthma.
1.4K
01:20Chronic Obstructive Pulmonary Disease-II: Pathophysiology
4.8K
Chronic Obstructive Pulmonary Disease (COPD) pathophysiology is intricate and multifaceted, involving a complex interplay of physiological processes. Understanding these mechanisms is crucial for effectively managing and treating COPD. Here is an in-depth look at the critical elements in the pathophysiology of COPD:
Chronic Inflammation
Chronic Inflammation
4.8K
01:29Asthma-I: Introduction
3.6K
Asthma is a chronic respiratory ailment that requires careful management due to its varying symptoms and influencing factors. It is characterized by airway inflammation, bronchial hyperresponsiveness, and reversible airflow obstruction, leading to symptoms like wheezing, shortness of breath, chest tightness, and coughing. The symptom frequency and intensity may vary considerably over time. It is also linked to immune system responses to allergens and irritants, highlighting the complex...
3.6K
01:19Antiasthma Drugs: Leukotriene Modifiers
1.9K
Leukotriene modifiers, or cysteinyl leukotriene receptor antagonists, are medications used to manage chronic asthma. These agents target specific inflammatory mediators produced during arachidonic acid metabolism, an essential process in generating inflammation in the body.
Leukotriene modifiers work through two distinct mechanisms:
Leukotriene modifiers work through two distinct mechanisms:
1.9K
01:25Antiasthma Drugs: β2-Adrenoceptor Agonists
1.8K
Bronchodilators are critical in managing asthma, a chronic respiratory condition characterized by airway constriction due to inflammation and hyper-reactivity. Specifically, bronchodilators ease this constriction by relaxing the bronchial muscles, facilitating easier breathing.
One class of bronchodilators includes β2-adrenoceptor agonists. These agents target the β2-adrenoceptors located on bronchial smooth muscle cells. By stimulating these receptors, β2-agonists induce...
One class of bronchodilators includes β2-adrenoceptor agonists. These agents target the β2-adrenoceptors located on bronchial smooth muscle cells. By stimulating these receptors, β2-agonists induce...
1.8K